ALPRAZOLAM IN PANIC DISORDER AND AGORAPHOBIA - RESULTS FROM A MULTICENTER TRIAL .1. EFFICACY IN SHORT-TERM TREATMENT

被引:0
|
作者
BALLENGER, JC
BURROWS, GD
DUPONT, RL
LESSER, IM
NOYES, R
PECKNOLD, JC
RIFKIN, A
SWINSON, RP
机构
[1] UNIV MELBOURNE, DEPT PSYCHIAT, PARKVILLE, VIC 3052, AUSTRALIA
[2] UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, DEPT PSYCHIAT, TORRANCE, CA 90509 USA
[3] UNIV IOWA, DEPT PSYCHIAT, IOWA CITY, IA 52242 USA
[4] MCGILL UNIV, DEPT PSYCHIAT, MONTREAL H3A 2T5, QUEBEC, CANADA
[5] CUNY MT SINAI SCH MED, DEPT PSYCHIAT, NEW YORK, NY 10029 USA
[6] TORONTO GEN HOSP, DEPT PSYCHIAT, TORONTO M5G 1L7, ONTARIO, CANADA
[7] CTR BEHAV MED, ROCKVILLE, MD USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:413 / 422
页数:10
相关论文
共 50 条
  • [1] ALPRAZOLAM IN PANIC DISORDER AND AGORAPHOBIA - RESULTS FROM A MULTICENTER TRIAL
    BALLENGER, JC
    BURROWS, GD
    DUPONT, RL
    LESSER, IM
    NOYES, R
    PECKNOLD, JC
    RIFKIN, A
    SWINSON, RP
    HOSPITAL FORMULARY, 1991, 26 : 14 - 27
  • [2] ALPRAZOLAM IN PANIC DISORDER AND AGORAPHOBIA - RESULTS FROM A MULTICENTER TRIAL .3. DISCONTINUATION EFFECTS
    PECKNOLD, JC
    SWINSON, RP
    KUCH, K
    LEWIS, CP
    ARCHIVES OF GENERAL PSYCHIATRY, 1988, 45 (05) : 429 - 436
  • [3] SEROTONIN, PANIC DISORDER AND AGORAPHOBIA - SHORT-TERM AND LONG-TERM EFFICACY OF CITALOPRAM IN PANIC DISORDERS
    HUMBLE, M
    WISTEDT, B
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 : 21 - 39
  • [4] ADVERSE-EFFECTS ASSOCIATED WITH THE SHORT-TERM TREATMENT OF PANIC DISORDER WITH IMIPRAMINE, ALPRAZOLAM OR PLACEBO
    CASSANO, GB
    TONI, C
    PETRACCA, A
    DELTITO, J
    BENKERT, O
    CURTIS, G
    HIPPIUS, H
    MAIER, W
    SHERA, D
    KLERMAN, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1994, 4 (01) : 47 - 53
  • [5] ASSESSING THE EFFICACY OF TREATMENTS FOR PANIC DISORDER AND AGORAPHOBIA .1. METHODOLOGICAL PROBLEMS
    BANDELOW, B
    HAJAK, G
    HOLZRICHTER, S
    KUNERT, HJ
    RUTHER, E
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (02) : 83 - 93
  • [6] Long-term efficacy of cognitive behavioural therapy for panic disorder with agoraphobia: preliminary results from a randomized controlled trial
    Gloster, A.
    Hoefler, M.
    Einsle, F.
    Wittchen, H. U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S361 - S361
  • [7] The role of depression in the treatment outcomes of a multicenter randomized trial of CBT for panic disorder and agoraphobia
    Emmrich, A.
    Beesdo-Baum, K.
    Gloster, A. T.
    Knappe, S.
    Hofler, M.
    Deckert, J.
    Gerlach, A. L.
    Lang, T.
    Richter, J.
    Wittchen, H. U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S365 - S365
  • [8] Efficacy of Alprazolam monotherapy vs. Alprazolam plus Fluvoxamine in long term treatment for panic disorder
    Mihailescu, R
    Gherghel, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S55 - S56
  • [9] Depression Does Not Affect the Treatment Outcome of CBT for Panic and Agoraphobia: Results from a Multicenter Randomized Trial
    Emmrich, Angela
    Beesdo-Baum, Katja
    Gloster, Andrew T.
    Knappe, Susanne
    Hoefler, Michael
    Arolt, Volker
    Deckert, Juergen
    Gerlach, Alexander L.
    Hamm, Alfons
    Kircher, Tilo
    Lang, Thomas
    Richter, Jan
    Stroehle, Andreas
    Zwanzger, Peter
    Wittchen, Hans-Ulrich
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2012, 81 (03) : 161 - 172
  • [10] A placebo-controlled trial of venlafaxine XR in the short-term treatment of panic disorder
    Liebowtiz, M
    Asnis, G
    Tzanis, E
    Whitaker, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S370 - S370